5-HT(2A) agonists have been shown in a variety of studies to increase brain-derived neurotrophic factor levels in the prefrontal cortex, and then studies with ibogaine more recently have been shown to increase glial cell derived neurotrophic factors, specifically in the ventral tegmental area that correlates with the changes in synaptic plasticity, so that's the first question, 